ARCHIVES

New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB.

This article is from The Cancer Letter archive.

Vol. 30 No. 38 | October 8, 2004

Download PDF Visit The Full Archive

Related Articles

Cancer Control Progress, Challenge Mark ACS Observance

October 18, 1991

In Brief: In Vitro Systems Will Be 90% Reliable, Ames Says; GAO Asks For Reassessment of Saccharin

October 1, 1976

NTP Plans Look At Radiation, Viruses, In Carcinogen Report.

July 27, 2001

Obit: John Ultmann, A Leader In Clinical Oncology.

October 27, 2000

Cell Genesys Begins Phase II Trial Of Gvax Vaccine For Pancreatic Cancer.

November 30, 2001

In Brief: HEW Opposes Research Contract Peer review; Congressman Blass Inadequate Grant Funds

May 10, 1974